Lonza Group Ltd Share Price Other OTC
Equities
LZAGY
US54338V1017
Biotechnology & Medical Research
Sales 2024 * | 6.64B 7.29B 581B | Sales 2025 * | 7.44B 8.17B 652B | Capitalization | 38.06B 41.79B 3,332B |
---|---|---|---|---|---|
Net income 2024 * | 904M 992M 79.13B | Net income 2025 * | 1.11B 1.22B 97.51B | EV / Sales 2024 * | 6.06 x |
Net Debt 2024 * | 2.18B 2.39B 190B | Net Debt 2025 * | 2.47B 2.71B 216B | EV / Sales 2025 * | 5.44 x |
P/E ratio 2024 * |
42.7
x | P/E ratio 2025 * |
34.2
x | Employees | - |
Yield 2024 * |
0.85% | Yield 2025 * |
0.98% | Free-Float | 95.87% |
Latest transcript on Lonza Group Ltd
Managers | Title | Age | Since |
---|---|---|---|
Albert Baehny
CEO | Chief Executive Officer | 72 | 24/04/17 |
Philippe Deecke
DFI | Director of Finance/CFO | 52 | 30/11/21 |
Maria Nunez
COO | Chief Operating Officer | 55 | 31/07/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Barbara Richmond
BRD | Director/Board Member | 63 | 15/04/14 |
Director/Board Member | 66 | 15/04/14 | |
Marion Helmes
BRD | Director/Board Member | 58 | 04/05/22 |
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B | |
-16.98% | 10.07B |